Accès ouvert déclaré
2023
article
Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
Anita van de Munckhof, Afshin Borhani‐Haghighi, Sanjith Aaron, Katarzyna Krzywicka, Mayte Sánchez van Kammen, Charlotte Cordonnier, Timothy Kleinig, Thalia S. Field, Sven Poli, Robin Lemmens, Adrian Scutelnic, Erik Lindgren, Jiangang Duan, Yıldız Arslan, Eric CM van Gorp, Johanna A. Kremer Hovinga, Albrecht Günther, Katarina Jood, Turgut Tatlisumak, Jukka Putaala, Mirjam R. Heldner, Marcel Arnold, Diana Aguiar de Sousa, Mohammad Wasay, Antonio Araúz, Adriana Bastos Conforto, José M. Ferro, Jonathan M. Coutinho, Joshua Mbroh, Alfonso Ciccone, Matthias Wittstock, Julian Zimmermann, Felix J. Bode, Mona Skjelland, Vanessa Dizonno, Annemie Devroye, Sini Hiltunen, Marco Petruzzellis, Tamam Bakchoul, Marcel Levi, Saskia Middeldorp, Aarti Sharma, Abdoreza Ghoreishi, Ahmed Elkady, A. Dal Negro, Alexander Gutschalk, Alina Buture, Álvaro Cervera, Ana Paiva Nunes, A. R. Baños, Andreas Tiede, Anil M. Tuladhar, Annerose Mengel, Antonio Medina, Avinash Aujayeb, Balakrishnan Ramasamy, Barbara Casolla, Neil J. Spratt, Bentolhoda Ziaadini, Boby Varkey Maramattom, Brian Buck, Carlos García-Esperón, Caroline Vayne, Christian Jacobi, Christian Pfrepper, Deepti Bal, Domenico Sergio Zimatore, Dominik Michalski, Dylan Blacquière, Elias Johansson, Elisa Cuadrado‐Godia, Elyar Sadeghi‐Hokmabadi, Emmanuel Carrera, Emmanuel de Maistre, Espen Saxhaug Kristoffersen, Etrat Hooshmandi, Fabrice Bonneville, Fabrice Vuillier, Fabrizio Giammello, Florindo d’Onofrio, Georgios Tsivgoulis, Giosué Gulli, Hans Katzberg, Igor Sibon, Irem Baharoglu, Jaime Masjuán, João Fernandes, Johann Pelz, Jorge Octavio López Esparza, Judith Schouten, Karl Ng, Laurent Derex, Laurent Puy, Leila Poorsaadat, Lenise Valler, Letícia Januzi de Almeida Rocha, Luis Manuel Murillo-Bonilla, Lukas Kellermair, Mar Morin Martin, Maria Sofia Cotelli, María Hernández‐Pérez, Marialuisa Zedde, Mariana Carvalho Dias, Marta Carvalho, Masoud Ghiasian, Meenakshisundaram Umaiorubahan, Mehrdad Roozbeh, Michele Romoli, Miguel Miranda, Miriam Wronski, Mohammad Saadatnia, M. Poggio, Mostafa Almasi‐Dooghaee, N Mir, Nasli Ichaporia, Naveen Kumar Paramasivan, Nicolas Raposo, Nima Fadakar, Nyika D. Kruyt, Olivier Detante, Pankaj Sharma, Paolo Candelaresi, Pasquale Scoppettuolo, Peggy Reiner, PN Sylaja, Ravi Kumar Karunakaran, Ricardo Vieira, Rolf Kern, Rudy Goh, Sapna Erat Sreedharan, Séan Murphy, Serge Timsit, Shelagh B. Coutts, Shyam Sundar Sharma, Silvia Schoenenberger, Simon Nagel, Subhash Kaul, Theodoros Karapanayiotides, Thomas Gattringer, Thomas Mathew, Thorsten Bartsch, Vincenzo Palma, Zahra Mirzaasgari, Zohreh Zamani, Alireza Mirahmadizadeh, Alonso Gutiérrez‐Romero, Ivan Iván Valdes-Ferrer, Santa Elizabeth Ceballos‐Liceaga, Ana María Santibáñez-Copado
8Citations signalées, ce qui n’est pas une note de qualité
27Institutions déclarées
16Pays d’affiliation déclarés
Rattachement africain : nl, ir, in, fr, au, ca, de, ch, se, cn, tr, fi, pt, pk, mx, br.
Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Adenovirus-based COVID-19 vaccines are extensively used in low- and middle-income countries (LMICs). Remarkably, cases of cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (CVST-VITT) have rarely been reported from LMICs. Aims: We studied the frequency, manifestations, treatment, and outcomes of CVST-VITT in LMICs. Methods: We report data from an international registry on CVST after COVID-19 vaccination. VITT was classified according to the Pavord criteria. We compared CVST-VITT cases from LMICs to cases from high-income countries (HICs). Results: Until August 2022, 228 CVST cases were reported, of which 63 were from LMICs (all middle-income countries [MICs]: Brazil, China, India, Iran, Mexico, Pakistan, Turkey). Of these 63, 32 (51%) met the VITT criteria, compared to 103 of 165 (62%) from HICs. Only 5 of the 32 (16%) CVST-VITT cases from MICs had definite VITT, mostly because anti-platelet factor 4 antibodies were often not tested. The median age was 26 (interquartile range [IQR] 20–37) versus 47 (IQR 32–58) years, and the proportion of women was 25 of 32 (78%) versus 77 of 103 (75%) in MICs versus HICs, respectively. Patients from MICs were diagnosed later than patients from HICs (1/32 [3%] vs. 65/103 [63%] diagnosed before May 2021). Clinical manifestations, including intracranial hemorrhage, were largely similar as was intravenous immunoglobulin use. In-hospital mortality was lower in MICs (7/31 [23%, 95% confidence interval (CI) 11–40]) than in HICs (44/102 [43%, 95% CI 34–53], p = 0.039). Conclusions: The number of CVST-VITT cases reported from LMICs was small despite the widespread use of adenoviral vaccines. Clinical manifestations and treatment of CVST-VITT cases were largely similar in MICs and HICs, while mortality was lower in patients from MICs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
- Date Crossref
- 30/06/2023
- Éditeur
- SAGE Publications
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Les sujets associés
Heparin-Induced Thrombocytopenia and ThrombosisCerebral Venous Sinus ThrombosisPlatelet Disorders and Treatments